Oscar Health (OSCR) Cash & Current Investments (2020 - 2026)

Oscar Health (OSCR) has 7 years of Cash & Current Investments data on file, last reported at $6.8 billion in Q1 2026.

• Quarterly Cash & Current Investments rose 127.57% year-over-year to $6.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.8 billion (up 127.57% YoY) and the FY2025 annual result came in at $4.0 billion, up 85.47% from the prior year.
• Cash & Current Investments improved to $6.8 billion in Q1 2026, from $4.0 billion in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $6.8 billion in Q1 2026 to a low of $1.7 billion in Q3 2024.
• A 5-year average of $3.2 billion and a median of $3.0 billion in 2022 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2024 — Cash & Current Investments tumbled 30.04% — and 2026, when it soared 127.57%.
• Tracing OSCR's Cash & Current Investments over 5 years: stood at $3.0 billion in 2022, then retreated by 13.39% to $2.6 billion in 2023, then dropped by 15.96% to $2.2 billion in 2024, then soared by 85.47% to $4.0 billion in 2025, then jumped by 70.39% to $6.8 billion in 2026.
• The last three Cash & Current Investments figures came in at $6.8 billion (Q1 2026), $4.0 billion (Q4 2025), and $3.0 billion (Q3 2025), per Business Quant data.